Vera P Krymskaya

9PUBLICATIONS

39CO-AUTHORS

Gene and molecular therapyHaematological tumoursCancer geneticsMolecular targetsImmunogenetics (incl. genetic immunology)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jul 28, 2026

Correction: Bähr et al. Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis. Biomolecules 2024, 14, 1236.

|Oct 09, 2025

mTOR dysregulation induces IL-6 and paracrine AT2 cell senescence impeding lung repair in lymphangioleiomyomatosis.

Roya Babaei-Jadidi, Debbie Clements, Yixin Wu

|Aug 01, 2025

Addressing Sex as a Biological Variable in Preclinical Models of Lung Disease: An Official American Thoracic Society Research Statement.

Krithika Lingappan, Isaac Kirubakaran Sundar, Y S Prakash

|Oct 26, 2024

Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis.

Stella Bähr, Ryan W Rue, Carly J Smith

|Aug 12, 2024

Neutrophil-avid nanocarrier uptake by STAT3 dominant-negative hyper-IgE syndrome patient neutrophils.

Kathryn M Rubey, Alexandra Freeman, Alexander R Mukhitov

|Mar 06, 2021

CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis.

Jilly Frances Evans, Kseniya Obraztsova, Susan M Lin

Pageof 2

Frequent Collaborators

Ryan W Rue

Carly J Smith

Stella Bähr

Simon R Johnson

Cormac Cosgrove

Dinesh Jaishankar

Daniel F Dilling

I Caroline Le Poole

Alexander R Mukhitov

Elena N Atochina-Vasserman

Frequent Collaborators

Ryan W Rue

Carly J Smith

Stella Bähr

Simon R Johnson